By Fineline Cube 
China-based Lead Healthcare Technology (Guangzhou) Co., Ltd reportedly raised close to RMB 100 million (USD 13.9 million) in an angel financing round led by Jiadao Private Capital. Other investors included Qiji Fund, CAS STAR, VIPASSANA Fund, and more. The proceeds will be used to accelerate technology research and development, product industrialization, and market expansion.
Company Overview and Focus
Founded in 2023, Lead Healthcare is focused on the independent research and development of AI-driven high-end life science instruments and bio intelligent manufacturing equipment. The company is building a comprehensive ecosystem that includes artificial intelligence (AI) algorithm systems, biochips, reagents, and consumables. Lead Healthcare is committed to creating microfluidic control, automation, intelligence, and system-level solutions for life science instruments, biopharmaceuticals, synthetic biology, and other fields.
Applications and Goals
Lead Healthcare aims to help increase efficiency and reduce costs in various fields, including biopharmaceuticals (antibody drugs, cell gene therapy, etc.), life science research, synthetic biology, biosafety, and areas such as cancer/anti-aging. By leveraging AI and bio intelligent manufacturing, the company seeks to drive innovation and improve outcomes in these critical areas.-Fineline Info & Tech